Drug Profile
Dimiracetam - Neurotune
Alternative Names: BND-11624; NT-11624Latest Information Update: 11 Sep 2018
Price :
$50
*
At a glance
- Originator Brane Discovery
- Developer Brane Discovery; Neurotune
- Class Non-opioid analgesics; Nootropics; Pyrrolidinones; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Musculoskeletal pain; Neuropathic pain
Most Recent Events
- 11 Sep 2018 No development reported - Phase-II for Neuropathic pain in Switzerland (PO)
- 02 Oct 2015 No recent reports of development identified - Phase-I for Musculoskeletal pain (In volunteers) in Switzerland (PO)
- 02 Oct 2015 No recent reports of development identified - Phase-II for Neuropathic pain in South Africa (PO)